Igny, June1, 2022 – Medical Devices Venture (ISIN: FR0014006PT9 – mnemo: MLMDV), a MedTech investment and acceleration platform, announces the entry of a new investor in Poladerme.
The entry in the capital of Poladerme (up to approximately 9%) of the Wongs group, through its subsidiary Top Plenty Ltd, is part of the strategy of development of the activities of Poladerme with the preparation of a distribution network for the products of Poladerme. The Wong Group is a major player in Hong Kong’s technology, real estate development and strategic investments. The Wongs Group invests in various sectors including new technologies and health. He identified in Poladerme an innovative dermatological solution, adapted to the needs of the market.
Loïc Poirier, President of Poladerme declares “We are proud to count the Wongs group among the shareholders of Poladerme. This group is developing many activities in Asia and we intend to conclude a distribution contract with WONGS for Poladerme’s products in this region, which pays particular attention to activities dealing with dermatology and cosmetics. This entry into the capital of Poladerme is also a token of confidence in the relevance of the project and will enable us to accelerate development outside Europe as soon as we enter the marketing phase.”